![Dietmar Berger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dietmar Berger
Technik-/Wissenschafts-/F&E-Leiter bei
GILEAD SCIENCES, INC.
Vermögen: 2 Mio $ am 30.06.2026
Profil
Dietmar P. Berger bekleidet die Position des Chief Medical Officer & Global Head-Development bei Sanofi. In seiner bisherigen Laufbahn hatte er die Position des Global Head-Research & Development bei Atara Biotherapeutics, Inc. inne, war Leiter des Klinischen Forschungszentrums am Universitätsklinikum Freiburg, Vice President-Clinical Hematology & Oncology bei Genentech, Inc. und Leiter des Klinischen Forschungszentrums am The Scripps Research Institute. Dr. Berger erhielt ein Diplom und einen Doktortitel von der Universität Freiburg.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.06.2026 | 19.252 ( 0 % ) | 2 Mio $ | 30.06.2026 |
Aktuelle Nachrichten zu Dietmar Berger
Aktive Positionen von Dietmar Berger
| Unternehmen | Position | Beginn |
|---|---|---|
| GILEAD SCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.01.2025 |
| ARCUS BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 06.02.2025 |
University of Freiburg
 University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Dietmar Berger
| Unternehmen | Position | Ende |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.05.2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01.05.2018 |
| INHIBRX, INC. | Präsident | - |
| SANOFI | Technik-/Wissenschafts-/F&E-Leiter | - |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Dietmar Berger
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
University of Freiburg
University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universitätsklinikum Freiburg
 Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Operates as a teaching hospital | Health Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
